Bio‑Rad (BIO) President Jonathan DiVincenzo Receives RSUs; 668 Shares Withheld

What Happened

• Jonathan P. DiVincenzo, President & COO of Bio‑Rad Laboratories (BIO), received a grant of 6,326 restricted stock units (RSUs) on 2026-09-04 and had 1,712 RSUs convert to shares on 2026-09-05. The conversion/vesting is reported as a derivative exercise (code M) at $0.00 per share. To cover withholding tax, 668 of the newly issued shares were withheld/disposed (code F) at $386.11 per share, totaling $257,921. Net shares delivered to him from the vesting event: 1,044 shares.

Key Details

• Dates: RSU grant 2026-09-04; RSU vest/convert and withholding 2026-09-05; Form 4 filed 2026-09-09.
• Prices/values: Conversion recorded at $0.00 (typical for RSU vesting); 668 shares withheld at $386.11 each = $257,921.
• Share counts: 6,326 RSUs granted; 1,712 RSUs vested/converted; 668 withheld for taxes; net 1,044 shares issued to insider.
• Footnotes: RSUs represent contingent rights to one share each and vest over four years (25% after one year, remainder quarterly thereafter).
• Filing timeliness: Filing date is 2026-09-09; the report does not state a late filing flag.

Context

• This was a routine equity award/vesting event (grant + RSU vesting) rather than an open‑market buy or deliberate sale by the insider. The withholding of 668 shares is a common tax‑withholding action (code F) and does not necessarily indicate a change in the insider’s view of the company.